News

For critically ill patients arriving at the emergency department, the drug ketamine can safely provide analgesia, sedation and amnesia for rapid, life-saving intubation, despite decades-old studies that suggested it raised intracranial pressure.

Genes and pathways identified could inform new approaches to treatment and address acute need for drug development for this disorder.

Proprietary microRNA diagnostic for identification of four major subtypes of kidney cancer now available in all 50 U.S. states.

Allowed claims of Manoharan '478 application cover GalNAc-conjugates independent of length, sequence, and disease target.

Renowned specialists to support development of Delenex’ advancing pipeline.

Co-promotion agreement to facilitate genomic biomarker discovery.

New therapies for treating Type 2 diabetes and obesity.

Exclusive global license from University of Tokyo enables development of QIAGEN assays for SF3B1 mutations, including NGS gene panels, for blood cancers.

A study involving nearly 27,000 older adults on five continents found that nearly 1 in 10 met criteria for pre-dementia based on a simple test that measures how fast people walk and whether they have cognitive complaints.

Hooked onto glasses, new optical device may be able to detect diabetic autonomic neuropathy sooner, leading to better treatment outcomes A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated.